Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2019 1
2020 7
2021 8
2022 13
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States.
Winter A, Liu N, Surinach A, Fanale M, Yu KS, Narkhede M. Winter A, et al. Among authors: surinach a. Clin Lymphoma Myeloma Leuk. 2023 Jul;23(7):527-534. doi: 10.1016/j.clml.2023.03.015. Epub 2023 Mar 30. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37121857 Free article.
The Current Landscape and Emerging Applications for Real-World Data in Diagnostics and Clinical Decision Support and its Impact on Regulatory Decision Making.
Baumfeld Andre E, Carrington N, Siami FS, Hiatt JC, McWilliams C, Hiller C, Surinach A, Zamorano A, Pashos CL, Schulz WL. Baumfeld Andre E, et al. Among authors: surinach a. Clin Pharmacol Ther. 2022 Dec;112(6):1172-1182. doi: 10.1002/cpt.2565. Epub 2022 Apr 29. Clin Pharmacol Ther. 2022. PMID: 35213741 Free PMC article. Review.
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States.
Barta SK, Liu N, DerSarkissian M, Chang R, Ye M, Duh MS, Surinach A, Fanale M, Yu KS. Barta SK, et al. Among authors: surinach a. Clin Lymphoma Myeloma Leuk. 2024 Feb;24(2):e21-e32.e4. doi: 10.1016/j.clml.2023.10.001. Epub 2023 Oct 11. Clin Lymphoma Myeloma Leuk. 2024. PMID: 37919137 Free article. Clinical Trial.
Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk.
Davies MR, Martinec M, Walls R, Schwarz R, Mirams GR, Wang K, Steiner G, Surinach A, Flores C, Lavé T, Singer T, Polonchuk L. Davies MR, et al. Among authors: surinach a. Cell Rep Med. 2020 Aug 25;1(5):100076. doi: 10.1016/j.xcrm.2020.100076. eCollection 2020 Aug 25. Cell Rep Med. 2020. PMID: 33205069 Free PMC article.
38 results